Sunday - December 22, 2024

Covalent Targeting of E3 Ligases

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- NOVARTIS AG, Basel, Switzerland has been assigned a patent (No. US 12161648 B2, initially filed Oct. 9, 2019) developed by eight inventors Jessica Spradlin, Berkeley, California; Carl C. Ward, Berkeley, California; Daniel K. Nomura, Walnut Creek, California; Markus Schirle, Cambridge, Massachusetts; John A. Tallarico, Cambridge, Massachusetts; Jeffrey McKenna, Cambridge, Massachusetts; Thomas John Maimone, Richmond, California; and Xirui Hu, Cambridge, Massachus . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Covalent Targeting of E3 Ligases

Information Request Form

Copyright Targeted News Service 2024